The opioid pendulum: Balancing the risks and benefits – Dr Meghna Jani speaks to Arthritis Digest Posted: Friday, July 7, 2023 For Arthritis Digest magazine, Manchester BRC researcher Dr Meghna Jani discusses balancing the risks and benefits of using opioids to treat pain for people with musculoskeletal conditions. Continue reading full article: The opioid pendulum: Balancing the risks and benefits – Dr Meghna Jani speaks to Arthritis Digest
Transitioning from paediatric to adult rheumatology services – Dr Jenny Humphreys speaks to Arthritis Digest Posted: Thursday, May 25, 2023 For Arthritis Digest magazine, Dr Jenny Humphreys explains what is involved during the transition from adult to paediatric services for people with juvenile idiopathic arthritis. Continue reading full article: Transitioning from paediatric to adult rheumatology services – Dr Jenny Humphreys speaks to Arthritis Digest
Identifying biomarkers to improve treatment outcomes for rheumatoid arthritis patients – Dr Darren Plant speaks to Arthritis Digest Posted: Thursday, March 2, 2023 For Arthritis Digest magazine, Dr Darren Plant explains how the future will see us identify biomarkers to improve rheumatoid arthritis treatment outcomes. Continue reading full article: Identifying biomarkers to improve treatment outcomes for rheumatoid arthritis patients – Dr Darren Plant speaks to Arthritis Digest
Inflammatory arthritis diagnosis from past to present – Professor Anne Barton speaks to Arthritis Digest Posted: Thursday, January 26, 2023 Speaking to Arthritis Digest magazine, Professor Anne Barton explains how a diagnosis of inflammatory arthritis is life changing, but is no longer a life sentence. Continue reading full article: Inflammatory arthritis diagnosis from past to present – Professor Anne Barton speaks to Arthritis Digest
Interrupting the treatment of vulnerable people on immune-suppressing medicines, doubles their antibody response to COVID-19 booster vaccination Posted: Monday, July 11, 2022 A major clinical trial supported by Manchester BRC researchers has found that by interrupting the treatment of vulnerable people on long-term immune supressing medicines for two weeks after a COVID-19 booster vaccination, their antibody response to the jab is doubled. Continue reading full article: Interrupting the treatment of vulnerable people on immune-suppressing medicines, doubles their antibody response to COVID-19 booster vaccination
Taking charge of arthritis – Dr James Bluett speaks to Arthritis Digest Posted: Friday, May 13, 2022 BRC Musculoskeletal researcher Dr James Bluett talks to Arthritis Digest magazine about how new tests will support patients with rheumatoid arthritis to regain control of their health. Continue reading full article: Taking charge of arthritis – Dr James Bluett speaks to Arthritis Digest
Manchester BRC musculoskeletal researchers publish ‘ground-breaking’ national guidelines for myositis Posted: Wednesday, May 11, 2022 Researchers from Manchester BRC’s Musculoskeletal (MSK) Theme have published the first guidelines on the care and treatment of patients with the rare autoimmune condition, myositis. Continue reading full article: Manchester BRC musculoskeletal researchers publish ‘ground-breaking’ national guidelines for myositis
Myositis and remote patient monitoring – Dr Alexander Oldroyd speaks to Arthritis Digest Posted: Monday, March 14, 2022 Continuing regular contributions from our BRC Musculoskeletal (MSK) theme researchers, Dr Alexander Oldroyd speaks to Arthritis Digest magazine about how technology could potentially help predict flares in patients with the autoimmune condition, myositis. Continue reading full article: Myositis and remote patient monitoring – Dr Alexander Oldroyd speaks to Arthritis Digest